1 Businesses and persons that cultivate, produce, process or trade in narcotics require a licence from the Swiss Agency for Therapeutic Products (Swissmedic26). Article 8 is reserved.27
2 The Federal Council shall regulate the requirements for the grant, expiry or withdrawal of the licence, and its form, content and term of validity.
25 Inserted by No I of the FA of 20 March 2008, in force since 1 July 2011 (AS 2009 2623, 2011 2559; BBl 2006 8573 8645).
26 Name in accordance with No I of the FA of 19 March 2021, in force since 1 Aug. 2022 (AS 2022 385; BBl 2020 6069). This change has been made throughout the text.
27 Amended by No I of the FA of 20 March 2008, in force since 1 July 2011 (AS 2009 2623, 2011 2559; BBl 2006 8573 8645).
1 Firmas e persunas che cultiveschan, produceschan, elavuran u fan commerzi cun narcotics dovran ina permissiun da l’Institut svizzer per products terapeutics (Swissmedic26). L’artitgel 8 resta resalvà.27
2 Las premissas per conceder, per stizzar u per retrair la permissiun, sco la furma, il cuntegn e la valaivladad da la permissiun regla il Cussegl federal.
25 Integrà tras la cifra I da la LF dals 20 da mars 2008, en vigur dapi il 1. da fan. 2011 (AS 2009 2623; 2011 2559; BBl 2006 8573, 8645).
26 Expressiun tenor la cifra I da la LF dals 19 da mars 2021, en vigur dapi il 1. d’avust 2022 (AS 2022 385; BBl 2020 6069). Questa midada è vegnida resguardada en l’entir decret.
27 Versiun tenor la cifra I da la LF dals 20 da mars 2008, en vigur dapi il 1. da fan. 2011 (AS 2009 2623; 2011 2559; BBl 2006 8573, 8645).
This document is not an official publication. Only the publication of the Federal Chancellery is legally binding.
Il presente documento non è una pubblicazione ufficiale. Fa unicamente fede la pubblicazione della Cancelleria federale. Ordinanza sulle pubblicazioni ufficiali, OPubl.